Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.
Clinuvel Pharmaceuticals Limited has actively engaged in a stock buy-back, purchasing a total of 2,500 ordinary fully paid shares on the previous day, adding to the 50,190 shares already bought back. This move is part of an ongoing market buy-back program, details of which were updated in their latest ASX announcement dated September 5, 2024.
For further insights into AU:CUV stock, check out TipRanks’ Stock Analysis page.